Literature DB >> 1715317

Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production.

D J Henderson1, I Naya, R V Bundick, G M Smith, J A Schmidt.   

Abstract

The immunosuppressive compounds FK-506, cyclosporin A (CsA) and rapamycin inhibit both the human and mouse mixed lymphocyte reactions (MLR) with IC50s of 2-5 x 10(-10) M for FK-506 and rapamycin and 10(-8) M for CsA. FK-506 and CsA were also potent inhibitors of A23187/PMA-stimulated IL-2 production by Jurkat and HuT-78 cells but had no effect on the response of mouse CTLL cells to IL-2. IC50 values for inhibition of IL-2 production closely matched those for inhibition of the MLR and both drugs were active only during the first 4-6 hr following stimulation. In contrast, rapamycin was a poor inhibitor of IL-2 production, although it inhibited cellular responses to IL-2. The IC50 values for these two activities indicated that neither alone accounted for rapamycin inhibition of the MLR. FK-506 and CsA affected IL-2 gene transcription in Jurkat cells by the same mechanism. Both inhibited the appearance of the transcription factor, NFAT, whereas rapamycin did not. The appearance of another transcription factor, NFK beta, was unaffected by all three drugs. The effects of FK-506 and CsA on IL-2 gene expression, therefore, are similar even though the two drugs act through distinct cytosolic receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715317      PMCID: PMC1384549     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Rapamycin for immunosuppression in organ allografting.

Authors:  R Y Calne; D S Collier; S Lim; S G Pollard; A Samaan; D J White; S Thiru
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

2.  Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.

Authors:  J E Kay; C R Benzie; M R Goodier; C J Wick; S E Doe
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

3.  The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Authors:  M J Tocci; D A Matkovich; K A Collier; P Kwok; F Dumont; S Lin; S Degudicibus; J J Siekierka; J Chin; N I Hutchinson
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

4.  A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.

Authors:  M W Harding; A Galat; D E Uehling; S L Schreiber
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

5.  Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.

Authors:  J C Reed; J D Alpers; P C Nowell; R G Hoover
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Nuclear factors interacting with the mitogen-responsive regulatory region of the interleukin-2 gene.

Authors:  M W Brunvand; A Schmidt; U Siebenlist
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

7.  Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene.

Authors:  A Weiss; R Shields; M Newton; B Manger; J Imboden
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

8.  Inhibition of the immune response by rapamycin, a new antifungal antibiotic.

Authors:  R R Martel; J Klicius; S Galet
Journal:  Can J Physiol Pharmacol       Date:  1977-02       Impact factor: 2.273

9.  T cell activation: differences in the signals required for IL 2 production by nonactivated and activated T cells.

Authors:  B Manger; A Weiss; C Weyand; J Goronzy; J D Stobo
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter.

Authors:  A Granelli-Piperno; P Nolan; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Natural product discovery: past, present, and future.

Authors:  Leonard Katz; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2016-01-06       Impact factor: 3.346

2.  NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Gunjan D Manocha; Atreyi Ghatak; Kendra L Puig; Susan D Kraner; Christopher M Norris; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction.

Authors:  A Salerno; C T Bonanno; N Caccamo; D Cigna; R Dominici; C Ferro; G Sireci; F Dieli
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  The effects of CP 17193, an immunosuppressive pyrazaloquinoline, on the development of spontaneous lupus disease in NZBW F1 hybrid mice.

Authors:  R V Bundick; R P Eady
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors.

Authors:  J Van Wauwe; F Aerts; H Walter; M de Boer
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

Review 6.  Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection.

Authors:  Ying-Chun Lo; Chen-Fang Lee; Jonathan D Powell
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

7.  The comparison of the impact of ghrelin and tacrolimus on vitreous cytokine levels in an experimental uveitis model.

Authors:  Fatih Cem Gül; Burak Turgut; Ferda Dağlı; Nevin Ilhan; Metin Özgen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-19       Impact factor: 3.117

Review 8.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease.

Authors:  Lalida Rojanathammanee; Kendra L Puig; Colin K Combs
Journal:  J Nutr       Date:  2013-03-06       Impact factor: 4.798

10.  The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response--an in vivo model of Th2-like activity.

Authors:  R V Bundick; R I Craggs; E Holness
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.